LRRK2 Cohort Consortium
The MJFF-led LRRK2 Cohort Consortium brought research groups together to speed efforts to move LRRK2 toward therapeutic relevance for patients.
The Consortium comprised three initiatives:
Each cohort includes LRRK2-positive Parkinson's patients, unaffected LRRK2 mutation carriers, idiopathic PD patients and control subjects. The Consortium contributed a common core dataset, and clinical data and biological samples are stored in a comprehensive Parkinson's database and biorepository.
Available Data and Biospecimens
MJFF makes data and biosamples available to the scientific community to conduct research on novel PD biomarkers. Biospecimens and data from the LRRK2 Cohort Consoritum (LCC) are available to qualified members of the research community.
Consortium biosamples are available through a collaborative resource access program with the National Institute for Neurological Disorders and Stroke (NINDS). Learn more and request access.
We also fund promising projects that use MJFF data and biospecimen collections. Submit a proposal budget using the proper template ( Industry/For Profit or Academic/Non-profit ) to email@example.com for review in parallel with the sample application submitted to NINDS.
LRRK2 Cohort Consortium Publications
Analysis from the LRRK2 Cohort Consortium has yielded notable findings. View a list of all publications and presentations from projects utilizing the resources.
Ongoing Research Utilizing LRRK2 Cohort Consortium Specimens
The following research studies have accessed LRRK2 Cohort Consortium samples. Researchers may apply to use biospecimens through NINDS .
Have a Question?